Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction

Journal of Lower Genital Tract Disease

Volumn 17, Issue 4, 2013, Pages 397-403

  Steinau, Martin ^a   Unger, Elizabeth R ^a   Hernandez, Brenda Y ^b   Goodman, Marc T ^c   Copeland, Glenn ^d   Hopenhayn, Claudia ^e   Cozen, Wendy ^f   Saber, Maria S ^f   Huang, Youjie ^g   Peters, Edward S ^h   Lynch, Charles F ⁱ   Wilkinson, Edward J ^j   Rajeevan, Mangalathu S ^a   Lyu, Christopher ^k   Saraiya, Mona ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f Queen Angels Hollywood Presbyt Med   (United States)

^g FLORIDA DEPARTMENT OF HEALTH   (United States)

^h LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

ⁱ UNIVERSITY OF IOWA   (United States)

^j UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^k BATTELLE MEMORIAL INSTITUTE   (United States)

more..

Author keywords

anal cancer; archived tissue; cancer registry; HPV typing; human papillomavirus

Indexed keywords

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER REGISTRY; DNA EXTRACTION; FEMALE; GENOTYPE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; RACE; SEX; TUMOR INVASION; UNITED STATES; VACCINE PRODUCTION; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84885319143     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31827ed372     Document Type: Article

References (18)

1. National Program of Cancer Registries. Cancer Incidence 1999-2009 (States only). Available at: http://wonder.cdc.gov/ cancer.html. 2012.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2008,National Cancer Institute. Bethesda,MD. Based on November 2010 SEER data submission, posted to the SEERWeb site, 2011. Available at: http://seer.cancer.gov/csr/1975-2008/. Accessed October 1, 2012.
3. De Vuyst H, Clifford GM, Nascimento MC, Madeline MM, Franceschi S. Prevalence and type distribuion of human paoillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124:1626-36.
4. Hoots BE, Palefsky JM, Jeanne M, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2010;124: 2375-83.
5. Kreimer AR, Gonzalez P, Katki HP, Porras C, Schiffman M, Rodriguez AC, et al. Efficacy of a bivalent HPV16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trail. Lancet Oncol 2011;12:862-70.
6. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, et al. HPV vaccine against anal HPV infection andanal intraepithelial neoplasia. N Engl J Med 2011;365:1576-85.
7. Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008;113(suppl 10):2892-900.
8. Frisch M, Fenger C, van den Brule AJ, Sorensen P, Meijer CL, Walboomers JM, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999;59: 753-7.
9. Abramowitz L, Jacguard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, et al. Human papillomavirus genoype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 2011;129:433-99.
10. Da Costa MM, Hogeboom CJ, Holly EA, Palefsky JM. Increased risk of high-grade anal neoplasia associated with a Human Papillomaivirus type 16 E6 sequence variant. J Infect Dis 2002;185:1229-37.
11. Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, Kuypers J, et al. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 1998;58:3839-44.
12. Steinau M, Patel SS, Unger ER. Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2011;13:377-81.
13. Swan DC, Limor JR, Duncan KL, Rajeevan MS, Unger ER. Human papillomavirus type 16 variant assignment by pyrosequencing. J Virol Methods 2006;136:166-70.
14. Swan DC, Rajeevan MS, Tortolero-Luna G, Follen M, Tucker RA, Unger ER. Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol 2005;96:695-700.
15. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Sha KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.
16. TachezyR, Jirasek T, SalakovaM, LufvidovaV,Kubecova M, Horak L, et al. Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology. APMIS 2007;115:195-203.
17. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of carcinogenic risks to Humans. Vol. 90, Human Papillomaviruses. Lyon, France: IARC; 2007.
18. Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, et al. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer 2009;125:2609-13.